特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
952954

ゲノミクス市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2020~2025年)

Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 125 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.81円
ゲノミクス市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2020~2025年)
出版日: 2020年07月18日
発行: IMARC Services Private Limited
ページ情報: 英文 125 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノミクス市場は、2014~2019年の間に約12%のCAGRで成長しました。ゲノミクスとは、生物のデオキシリボ核酸(DNA)に存在する遺伝物質の構造、機能、遺伝の研究を指します。診断、創薬、精密医療の開発、農業研究のための様々な消耗品、システム、ソフトウェア、サービスが含まれます。ゲノミクスに使用されるテクノロジーには、マイクロアレイ、シーケンシング、ポリメラーゼ連鎖反応(PCR)、核酸抽出および精製、単一細胞ゲノミクス分析などがあり、これらの技術は複雑な遺伝的問題を解決するのに非常に効果的です。 非侵襲的ながんスクリーニングに基づく研究の増加は、個別化医療への需要の高まりとともに、市場の成長を牽引する重要な要因の1つとなっています。また、慢性疾患の発生率上昇も市場の成長を後押ししています。バイオノミクスベースのアプリやテスト開発を含む、様々な技術的進歩が、成長要因として機能しています。さらに、バイオインフォマティクスの分野での大規模な研究開発 (R&D)活動や次世代シーケンシングサービスに対する需要増加などが、市場をさらに後押しすると予想されています。IMARC Groupは、 世界のゲノミクス市場が今後5年間、力強い成長を続けると予測しています。

当レポートでは、世界のゲノミクス市場の構造と動向について分析し、市場の全体的構造や、市場規模の推移・予測、コンポーネント別・アプリケーション別・技術別・エンドユーザー別・地域別の詳細動向、市場の求心力・競争情勢、主要企業のプロファイルなどについて調査しております。

第1章 序論

第2章 分析範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のゲノミクス市場

  • 市場概要
  • 市場規模の実績値
  • Covid-19の影響

第6章 コンポーネント別の市場区分

  • 製品
    • 主な種類
  • サービス
    • 主な種類

第7章 アプリケーション別の市場区分

  • 機能ゲノミクス
  • エピゲノミクス
  • バイオマーカー発見
  • 経路分析
  • その他

第8章 技術別の市場区分

  • シーケンス
  • マイクロアレイ
  • ポリメラーゼ連鎖反応
  • 核酸の抽出・精製
  • その他

第9章 エンドユーザー別の市場区分

  • 調査センター
  • 病院・診療所
  • 製薬・バイオテクノロジー企業
  • その他

第10章 地域別の市場区分

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 国別の市場区分

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターファイブフォース分析

第14章 価格指標

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2019
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2019
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2019
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2019
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2019
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: China: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: India: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: France: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2020-2025
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Genomics Market Structure
  • Table 8: Global: Genomics Market: Key Players
目次
Product Code: SR1019K88_Report

The global genomics market grew at a CAGR of around 12% during 2014-2019. Genomics refers to the study of the structure, function and inheritance of the genetic material present in the deoxyribonucleic acid (DNA) of an organism. It addresses the intrarelationship of all genes to identify their combined influence on the overall growth and development. It involves various consumables, systems, software and services for diagnostics, drug discovery, development of precision medicine and agricultural research. Some of the technologies used for genomics include microarray, sequencing, polymerase chain reaction (PCR), nucleic acid extraction and purification and single-cell genomics analysis. These techniques are highly effective in solving complex genetic problems.

The increasing adoption of non-invasive cancer screening-based research, along with the growing demand for personalized medicines, is one of the key factors driving the growth of the market. Furthermore, the rising incidences of chronic diseases is also providing a boost to the market growth. Clinical workflows are widely being integrated with genomic data for the production of targeted and personalized medicines and for studying the growth of newborn genetic screening programs and military genomics. This, along with the growing demand for genetically modified plants and organisms in the agriculture sector, is creating a positive impact on the market growth. Various technological advancements, including the development of genomics-based apps and tests, are acting as another major growth-inducing factor. Other factors, such as extensive research and development (R&D) activities in the field of bioinformatics and the increasing demand for next-generation sequencing services, are projected to drive the market further. Looking forward, IMARC Group expects the market the global genomics market to continue its strong growth during the next five years.

Breakup by Component:

  • Products
  • Instruments and Software
  • Consumables and Reagents
  • Services
  • Core Genomics Services
  • NGS-Based Services
  • Biomarker Translation Services
  • Computational Services
  • Others

Breakup by Application:

  • Functional Genomics
  • Epigenomics
  • Biomarkers Discovery
  • Pathway Analysis
  • Others

Breakup by Technology:

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

Breakup by End-User:

  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global genomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global genomics market?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global genomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.